161 related articles for article (PubMed ID: 17616678)
1. Tumor-suppressive activity of the cell death activator GRIM-19 on a constitutively active signal transducer and activator of transcription 3.
Kalakonda S; Nallar SC; Lindner DJ; Hu J; Reddy SP; Kalvakolanu DV
Cancer Res; 2007 Jul; 67(13):6212-20. PubMed ID: 17616678
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressive protein gene associated with retinoid-interferon-induced mortality (GRIM)-19 inhibits src-induced oncogenic transformation at multiple levels.
Kalakonda S; Nallar SC; Gong P; Lindner DJ; Goldblum SE; Reddy SP; Kalvakolanu DV
Am J Pathol; 2007 Oct; 171(4):1352-68. PubMed ID: 17823279
[TBL] [Abstract][Full Text] [Related]
3. Tumor-derived mutations in the gene associated with retinoid interferon-induced mortality (GRIM-19) disrupt its anti-signal transducer and activator of transcription 3 (STAT3) activity and promote oncogenesis.
Nallar SC; Kalakonda S; Lindner DJ; Lorenz RR; Lamarre E; Weihua X; Kalvakolanu DV
J Biol Chem; 2013 Mar; 288(11):7930-7941. PubMed ID: 23386605
[TBL] [Abstract][Full Text] [Related]
4. The cell death regulator GRIM-19 is an inhibitor of signal transducer and activator of transcription 3.
Zhang J; Yang J; Roy SK; Tininini S; Hu J; Bromberg JF; Poli V; Stark GR; Kalvakolanu DV
Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9342-7. PubMed ID: 12867595
[TBL] [Abstract][Full Text] [Related]
5. GRIM-19 represses the proliferation and invasion of cutaneous squamous cell carcinoma cells associated with downregulation of STAT3 signaling.
Wu N; Hui H; Cui L; Yang F
Biomed Pharmacother; 2017 Nov; 95():1169-1176. PubMed ID: 28926927
[TBL] [Abstract][Full Text] [Related]
6.
Cao F; Zhang Q; Chen W; Zheng F; Ran Q; He Y; Gao Y; Yao S
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29074558
[TBL] [Abstract][Full Text] [Related]
7. GRIM-19 mutations fail to inhibit v-Src-induced oncogenesis.
Kalakonda S; Nallar SC; Lindner DJ; Sun P; Lorenz RR; Lamarre E; Reddy SP; Kalvakolanu DV
Oncogene; 2014 Jun; 33(24):3195-204. PubMed ID: 23851499
[TBL] [Abstract][Full Text] [Related]
8. Plasmid-based Stat3-specific siRNA and GRIM-19 inhibit the growth of thyroid cancer cells in vitro and in vivo.
Wang GM; Ren ZX; Wang PS; Su C; Zhang WX; Liu ZG; Zhang L; Zhao XJ; Chen G
Oncol Rep; 2014 Aug; 32(2):573-80. PubMed ID: 24899100
[TBL] [Abstract][Full Text] [Related]
9. The effect of a gene associated with retinoid-interferon-induced mortality 19 (GRIM-19) on STAT3-induced gene expression in renal carcinoma.
Cui L; Meng Q; Wen J; Yan Z; Gao Z; Tian Y; Xu P; Lian P; Yu H
J Biochem; 2018 Oct; 164(4):285-294. PubMed ID: 29961871
[TBL] [Abstract][Full Text] [Related]
10. Gene associated with retinoid-interferon-induced mortality-19 suppresses growth of lung adenocarcinoma tumor in vitro and in vivo.
Wang T; Yan XB; Zhao JJ; Ye J; Jiang ZF; Wu DR; Xiao WH; Liu RY
Lung Cancer; 2011 Jun; 72(3):287-93. PubMed ID: 21040996
[TBL] [Abstract][Full Text] [Related]
11. Effects of plasmid-based Stat3-specific short hairpin RNA and GRIM-19 on PC-3M tumor cell growth.
Zhang L; Gao L; Li Y; Lin G; Shao Y; Ji K; Yu H; Hu J; Kalvakolanu DV; Kopecko DJ; Zhao X; Xu DQ
Clin Cancer Res; 2008 Jan; 14(2):559-68. PubMed ID: 18223232
[TBL] [Abstract][Full Text] [Related]
12. GRIM-19, a death-regulatory gene product, suppresses Stat3 activity via functional interaction.
Lufei C; Ma J; Huang G; Zhang T; Novotny-Diermayr V; Ong CT; Cao X
EMBO J; 2003 Mar; 22(6):1325-35. PubMed ID: 12628925
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of GRIM-19 promotes growth and migration of human glioma cells.
Zhang Y; Hao H; Zhao S; Liu Q; Yuan Q; Ni S; Wang F; Liu S; Wang L; Hao A
Cancer Sci; 2011 Nov; 102(11):1991-9. PubMed ID: 21827581
[TBL] [Abstract][Full Text] [Related]
14. GRIM-19 in Health and Disease.
Máximo V; Lima J; Soares P; Silva A; Bento I; Sobrinho-Simões M
Adv Anat Pathol; 2008 Jan; 15(1):46-53. PubMed ID: 18156812
[TBL] [Abstract][Full Text] [Related]
15. Curcumin synergistically increases effects of β-interferon and retinoic acid on breast cancer cells in vitro and in vivo by up-regulation of GRIM-19 through STAT3-dependent and STAT3-independent pathways.
Ren M; Wang Y; Wu X; Ge S; Wang B
J Drug Target; 2017 Mar; 25(3):247-254. PubMed ID: 27677346
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of GRIM-19 in cancer cells suppresses STAT3-mediated signal transduction and cancer growth.
Okamoto T; Inozume T; Mitsui H; Kanzaki M; Harada K; Shibagaki N; Shimada S
Mol Cancer Ther; 2010 Aug; 9(8):2333-43. PubMed ID: 20682646
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of GRIM-19 expression is associated with hyperactivation of STAT3-induced gene expression and tumor growth in human cervical cancers.
Zhou Y; Li M; Wei Y; Feng D; Peng C; Weng H; Ma Y; Bao L; Nallar S; Kalakonda S; Xiao W; Kalvakolanu DV; Ling B
J Interferon Cytokine Res; 2009 Oct; 29(10):695-703. PubMed ID: 19642906
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial GRIM-19 as a potential therapeutic target for STAT3-dependent carcinogenesis of gastric cancer.
Huang Y; Yang M; Hu H; Zhao X; Bao L; Huang D; Song L; Li Y
Oncotarget; 2016 Jul; 7(27):41404-41420. PubMed ID: 27167343
[TBL] [Abstract][Full Text] [Related]
19. [Correlations of GRIM-19 and its target gene product STAT3 to malignancy of human colorectal carcinoma].
Gong LB; Luo XL; Liu SY; Tao DD; Gong JP; Hu JB
Ai Zheng; 2007 Jul; 26(7):683-7. PubMed ID: 17626740
[TBL] [Abstract][Full Text] [Related]
20. Identification of a structural motif in the tumor-suppressive protein GRIM-19 required for its antitumor activity.
Nallar SC; Kalakonda S; Sun P; Ohmori Y; Hiroi M; Mori K; Lindner DJ; Kalvakolanu DV
Am J Pathol; 2010 Aug; 177(2):896-907. PubMed ID: 20595633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
